Table 3.
Peripapillary Choroidal Thickness Changes
| Measured Location | Mean (μm) | STDa (μm) | p-Value | |||
|---|---|---|---|---|---|---|
| Compared with Control Eye | Compared with Study Eye Baseline | |||||
| Inferior | Control (Fellow) Eye | 116.19 | 58.66 | – | – | |
| Study Eye | Baseline b | 149.36 | 60.74 | 0.033* | – | |
| Month 1 | 133.50 | 54.66 | 0.133 | 0.058 | ||
| Month 2 | 115.00 | 49.62 | 0.917 | 0.144 | ||
| Months 3-4 | 128.80 | 55.38 | 0.285 | 0.173 | ||
| Nasal | Control (Fellow) Eye | 142.94 | 56.41 | – | – | |
| Study Eye | Baseline b | 165.55 | 71.22 | 0.026* | – | |
| Month 1 | 159.08 | 68.74 | 0.046* | 0.833 | ||
| Month 2 | 124.50 | 49.40 | 0.917 | 0.273 | ||
| Months 3-4 | 151.20 | 70.69 | 0.508 | 0.066 | ||
| Superior | Control (Fellow) Eye | 180.03 | 66.11 | – | – | |
| Study Eye | Baseline b | 186.82 | 60.63 | 0.790 | – | |
| Month 1 | 222.40 | 42.40 | 0.345 | 0.891 | ||
| Month 2 | 158.67 | 78.07 | 0.917 | 0.080 | ||
| Months 3-4 | 175.35 | 60.25 | 0.959 | 0.779 | ||
| Temporal | Control (Fellow) Eye | 151.65 | 62.53 | – | – | |
| Study Eye | Baseline b | 182.60 | 84.15 | 0.386 | – | |
| Month 1 | 199.50 | 107.75 | 0.249 | 0.414 | ||
| Month 2 | 179.67 | 89.20 | 0.028* | 0.500 | ||
| Months 3-4 | 143.55 | 44.06 | 0.959 | 0.726 | ||
a STD = Standard Deviation
b Baseline = Measurement on the day of TASS diagnosis
* Statistically Significant